A Kenyan law that allows the importation and manufacture of generic antiretroviral drugs took effect on May 1, BBC News reports. Last June, the Kenyan Parliament passed the Industrial Properties Bill 2001, a measure that allows Kenya to suspend drug patents during a national health emergency. The law stipulates that Kenya must give drug manufacturers six months' notice before licensing other companies to import or produce generic versions of patented drugs.